InvestorsHub Logo
Followers 41
Posts 957
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Thursday, 03/21/2024 10:26:23 AM

Thursday, March 21, 2024 10:26:23 AM

Post# of 41122
PACV company and CEO warning

First 9 months 2022 sales: $30 million. First 9 months 2023 sales: $22 million

December 2022 deficit: $28,971,411. September 2023 deficit: $31,133,851.

As of September 2023, PACV has a notes payable balance of $16 million !!

$6 million assets
$28 million liabilities

"On September 6, 2023, the Company entered into a settlement agreement with Trillium Partners"
"It is estimated that the Company will, pursuant to the terms of the Settlement Agreement, issue to Trillium approximately $9,282,267.93 of Settlement Shares"

CEO maxed out issued shares to almost 900 million in September 2023, increased authorized from 900 million to 5 billion, completed reverse split, reduced authorize back down to 900 million, and is now rapidly issuing shares again, all within a few months and with no words to shareholders.

CEO puts out fake news to pump and dump, then will disappear for 8 months. This CEO will never lead a NASDAQ company and PACV will never be a NASDAQ company.

PACV is in very bad condition be ready for heavy pump and dumps to pay bills. CEO does not care if stock price is 0.00001 or $1 absolutely does not care at all about the stock price or shareholders. Been here for like 5 years.. rinse and repeat here at PACV. I will never buy PACV stock ever again and will advocate against anyone supporting this terrible OTC CEO.

If you can quickly flip for 10% congratulations. Holding PACV for longer than 1 day is the biggest risk in the stock market in my opinion.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PACV News